Oncowitan discloses a new publication, to highlight the anticancer potential of the well-established antibacterial drug nifuroxazide:

Bailly, C. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment, Drug Discovery Today (2019)

Bailly, C. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment, Drug Discovery Today (2019)

Read: https://doi.org/10.1016/j.drudis.2019.06.017

Categories: News